Showing 1 - 7 results of 7 for search 'Catherine Orrell', query time: 0.02s
Refine Results
-
1
-
2
Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients by Catherine Orrell, Franco Felizarta, André Nell, Thomas N. Kakuda, Ludo Lavreys, Steven Nijs, Lotke Tambuyzer, Rodica Van Solingen-Ristea, Frank L. Tomaka
Published 2015-01-01Get full text
Article -
3
PrEP preferences and early acceptability of injectable cabotegravir among pregnant and lactating people in Cape Town, South Africa: findings from the PrEPared to Choose study by Nafisa Wara, Carey Pike, Elzette Rousseau, Pippa Macdonald, Pakama Mapukata, Bryan Leonard, Keitumetse Lebelo, Risa Hoffman, Catherine Orrell, Linda‐Gail Bekker, Dvora Joseph Davey
Published 2025-07-01Get full text
Article -
4
The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans by Rosie Mngqibisa, Yashna Singh, Catherine Orrell, Johan Lombaard, Sandy Griffith, Conn Harrington, Ronald D’Amico, William Spreen, Marty St Clair, Christine Latham, Louise Garside, Rodica Van Solingen-Ristea, Veerle Van Eygen, Fafa Addo Boateng, Herta Crauwels, Prosperity Eneh, Ingrid Eshun-Wilsonova
Published 2025-07-01Get full text
Article -
5
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study). by Catriona Waitt, Catherine Orrell, Stephen Walimbwa, Yashna Singh, Kenneth Kintu, Bryony Simmons, Julian Kaboggoza, Mary Sihlangu, Julie-Anne Coombs, Thoko Malaba, Josaphat Byamugisha, Alieu Amara, Joshua Gini, Laura Else, Christie Heiburg, Eva Maria Hodel, Helen Reynolds, Ushma Mehta, Pauline Byakika-Kibwika, Andrew Hill, Landon Myer, Mohammed Lamorde, Saye Khoo
Published 2019-09-01Get full text
Article -
6
Emerging priorities for HIV service delivery. by Nathan Ford, Elvin Geng, Tom Ellman, Catherine Orrell, Peter Ehrenkranz, Izukanji Sikazwe, Andreas Jahn, Miriam Rabkin, Stephen Ayisi Addo, Anna Grimsrud, Sydney Rosen, Isaac Zulu, William Reidy, Thabo Lejone, Tsitsi Apollo, Charles Holmes, Ana Francisca Kolling, Rosina Phate Lesihla, Huu Hai Nguyen, Baker Bakashaba, Lastone Chitembo, Ghion Tiriste, Meg Doherty, Helen Bygrave
Published 2020-02-01Get full text
Article -
7
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, imple... by Shelly Karuna, Fatima Laher, Sufia Dadabhai, Pei‐Chun Yu, Doug Grove, Catherine Orrell, Joseph Makhema, Mina C. Hosseinipour, Carrie‐Anne Mathew, William Brumskine, Nyaradzo Mgodi, Philip Andrew, Lucio Gama, Carissa Karg, Gail Broder, Kagisho Baepanye, Jonathan Lucas, Michele Andrasik, Simbarashe Takuva, Manuel Villaran, Azwidihwi Takalani, Randall Tressler, Lydia Soto‐Torres, Amanda S. Woodward Davis, Ames Dhai, Ian M. Sanne, Myron S. Cohen, Lawrence Corey, Glenda Gray, Allan C. deCamp, Katharine J. Bar
Published 2025-06-01Get full text
Article